Bladder cancer--genetic overview. 2001

S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
Department of Urology, Bnai Zion Medical Center, 47 Golomb St., Haifa, Israel.

BACKGROUND This article review the serial genetic changes which are responsible to the initiation and progression of bladder cancer. Knowledge of the exact genetic alteration has a direct implication on the development of knew more sensitive and specific tool for an early diagnosis and better prognosis calculations. CONCLUSIONS Bladder cancer develop and progress through a series of genetic alterations. Understanding of the genetic mechanisms which lead to malignant transformation gave rise to the development of various genetic mechanisms which lead to malignant transformation gave rise to the development of various genetic tools providing better ability of early detection and more accurate prognosis prediction.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene

Related Publications

S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
January 1988, CA: a cancer journal for clinicians,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
January 1999, Advances in experimental medicine and biology,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
October 2018, British journal of nursing (Mark Allen Publishing),
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
December 1992, Urology,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
June 2020, AJR. American journal of roentgenology,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
July 2023, Current oncology reports,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
October 1985, Urology,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
January 1996, Cancer treatment and research,
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
October 2018, British journal of nursing (Mark Allen Publishing),
S Halachmi, and R Madeb, and A Kravtsov, and B Moskovitz, and N Halachmi, and O Nativ
May 2018, British journal of nursing (Mark Allen Publishing),
Copied contents to your clipboard!